Adcal-D3 reimbursement prices following list price changes
On the 20th November 2023, Kyowa Kirin International UK NewCo Ltd increased its list prices for the following Adcal-D3 products:
Product | Pack size | Previous list price | New list price from 20 November 2023 |
Adcal-D3 750mg/200unit caplets | 112 | £2.95 | £3.54 |
Adcal-D3 Lemon chewable tablets | 56 | £3.65 | £4.38 |
Adcal-D3 Lemon chewable tablets | 112 | £7.49 | £8.99 |
Adcal-D3 chewable tablets tutti frutti | 56 | £3.65 | £4.38 |
Adcal-D3 chewable tablets tutti frutti | 112 | £7.49 | £8.99 |
Under the price change mechanism rules, a list price change for branded medicines up to and including the 8th of the month takes effect for prescriptions dispensed in the following month. A price change after the 8th of the month will be applied for reimbursement purposes to prescriptions dispensed one month later.
Therefore, the new list prices for the Adcal-D3 preparations listed above will apply to reimbursement for prescriptions dispensed from January 2024. Any prescriptions submitted for payment for the dispensing month of December 2023 will be reimbursed as per the old list prices.
The prices of certain drugs may fluctuate from month to month and the ‘Price Change Mechanism’ was introduced to ensure that community pharmacy owners are appropriately reimbursed for the drugs they dispense. This mechanism was put in place to increase or decrease the reimbursement prices of drugs to catch up with any changes to market prices. The timing of any price change of a drug determines when the change to its reimbursement price comes into effect – which differs depending on whether the drug is a proprietary or generic product. Proprietary products A price change after the 8th of the month will be applied for reimbursement purposes to prescriptions dispensed one month later. Generic products (excluding Category M) For non-proprietary or generic products (mainly Category A products and excluding those listed as Category M), the reimbursement price change takes place one month earlier than proprietary products. Where price is based on a generic product a price change up to and including the 8th of the month takes effect for prescriptions dispensed in that same month. Any price change after the 8th takes effect in the following month.
For proprietary preparations, including those listed in Part VIIIA products where the price is based on a proprietary product (for e.g. Category C products), a price change up to and including the 8th of the month takes effect for prescriptions dispensed in the following month.